Iron Oxide Nanoparticles Functionalized with Macrocycle Antagonists for CXCR4 Receptor Targeting in Cancer Cells. Journal of Analytical Oncology, [S. l.], v. 13, p. 36–42, 2024. DOI: 10.30683/1927-7229.2024.13.06. Disponível em: https://mail.neoplasiaresearch.com/index.php/jao/article/view/794. Acesso em: 21 oct. 2025.